Arax Advisory Partners’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.1K Buy
4,717
+4,310
+1,059% +$47.5K ﹤0.01% 3397
2026
Q1
$4.67K Buy
407
+399
+4,988% +$5.27K ﹤0.01% 2816
2025
Q4
$121 Sell
8
-221
-97% -$3.37K ﹤0.01% 3799
2025
Q3
$3.35K Buy
+229
New +$3.01K ﹤0.01% 2981
2025
Q2
Sell
-55
Closed -$898 3158
2025
Q1
$898 Buy
+55
New +$965 ﹤0.01% 2333
2024
Q4
Sell
-32
Closed -$500 2648
2024
Q3
$500 Hold
32
﹤0.01% 2403
2024
Q2
$425 Buy
+32
New +$438 ﹤0.01% 2351

Other funds holding OFIX

Arax Advisory Partners's OFIX Position: Q2 2026 in Review

Arax Advisory Partners increased its Orthofix Medical (OFIX) stake by 1,059% in Q2 2026, buying an estimated $47.5K and bringing the position to 4,717 shares worth $43.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3397.

Arax Advisory Partners first reported a position in OFIX in Q2 2024 and has held it in 7 quarters since. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Arax Advisory Partners held 4,717 shares of Orthofix Medical worth $43.1K as of Q2 2026.
  • Arax Advisory Partners bought 4,310 Orthofix Medical shares in Q2 2026, an estimated $47.5K.
  • Orthofix Medical made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3397 holding.
  • Arax Advisory Partners first reported a position in Orthofix Medical in Q2 2024 and has held it in 7 quarters since.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.